These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 10772984
1. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Aronson JF, Grieder FB, Davis NL, Charles PC, Knott T, Brown K, Johnston RE. Virology; 2000 Apr 25; 270(1):111-23. PubMed ID: 10772984 [Abstract] [Full Text] [Related]
2. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB, Davis NL, Aronson JF, Charles PC, Sellon DC, Suzuki K, Johnston RE. Virology; 1995 Feb 01; 206(2):994-1006. PubMed ID: 7856110 [Abstract] [Full Text] [Related]
3. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB, Davis BK, Zhou XD, Chen SJ, Finkelman FD, Gause WC. Virology; 1997 Jul 07; 233(2):302-12. PubMed ID: 9217054 [Abstract] [Full Text] [Related]
4. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages. Grieder FB, Nguyen HT. Microb Pathog; 1996 Aug 07; 21(2):85-95. PubMed ID: 8844652 [Abstract] [Full Text] [Related]
5. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Davis NL, Brown KW, Greenwald GF, Zajac AJ, Zacny VL, Smith JF, Johnston RE. Virology; 1995 Sep 10; 212(1):102-10. PubMed ID: 7676619 [Abstract] [Full Text] [Related]
11. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Charles PC, Brown KW, Davis NL, Hart MK, Johnston RE. Virology; 1997 Feb 17; 228(2):153-60. PubMed ID: 9123821 [Abstract] [Full Text] [Related]
12. Venezuelan equine encephalitis virus in the guinea pig model: evidence for epizootic virulence determinants outside the E2 envelope glycoprotein gene. Greene IP, Paessler S, Anishchenko M, Smith DR, Brault AC, Frolov I, Weaver SC. Am J Trop Med Hyg; 2005 Mar 17; 72(3):330-8. PubMed ID: 15772331 [Abstract] [Full Text] [Related]
13. Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo. McCurdy K, Joyce J, Hamilton S, Nevins C, Sosna W, Puricelli K, Rayner JO. Virology; 2011 Jun 20; 415(1):20-9. PubMed ID: 21507450 [Abstract] [Full Text] [Related]
14. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Phillpotts RJ, O'brien L, Appleton RE, Carr S, Bennett A. Vaccine; 2005 Feb 18; 23(13):1615-23. PubMed ID: 15694514 [Abstract] [Full Text] [Related]
18. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates. Turell MJ, O'Guinn ML, Parker MD. Am J Trop Med Hyg; 2003 Feb 18; 68(2):218-21. PubMed ID: 12641414 [Abstract] [Full Text] [Related]
19. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S, Ni H, Petrakova O, Fayzulin RZ, Yun N, Anishchenko M, Weaver SC, Frolov I. J Virol; 2006 Mar 18; 80(6):2784-96. PubMed ID: 16501087 [Abstract] [Full Text] [Related]